Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and Genetic Features of Chinese Adult Patients With Chronic Non-Bacterial Osteomyelitis: A Single Center Report. | Front Immunol | 2022 | 35422809 | PubTator, text mining | PubMed |
| Planned Preterm Delivery and Treatment of Severe Infantile FEVR With Osteoporosis-Pseudoglioma Syndrome. | Ophthalmic Surg Lasers Imaging Retina | 2022 | 35417292 | PubTator, text mining | PubMed |
| A novel frameshift variant in the TSPAN12 gene causes autosomal dominant FEVR. | Mol Genet Genomic Med | 2022 | 35417085 | PubTator, text mining | PubMed |
| Relationship between rs7586085, GALNT3 and CCDC170 gene polymorphisms and the risk of osteoporosis among the Chinese Han population. | Sci Rep | 2022 | 35414641 | PubTator, text mining | PubMed |
| Morphogen Signals Shaping the Gastric Glands in Health and Disease. | Int J Mol Sci | 2022 | 35408991 | PubTator, text mining | PubMed |
| MiRNA-320a-5p contributes to the homeostasis of osteogenesis and adipogenesis in bone marrow mesenchymal stem cell. | Regen Ther | 2022 | 35402661 | PubTator, text mining | PubMed |
| Presentation of potential genes and deleterious variants associated with non-syndromic hearing loss: a computational approach. | Genomics Inform | 2022 | 35399004 | PubTator, text mining | PubMed |
| Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly. | J Exp Clin Cancer Res | 2022 | 35395804 | PubTator, text mining | PubMed |
| FZD4 in a Large Chinese Population With Familial Exudative Vitreoretinopathy: Molecular Characteristics and Clinical Manifestations. | Invest Ophthalmol Vis Sci | 2022 | 35394490 | PubTator, text mining | PubMed |
| Evaluation of growth, puberty, osteoporosis, and the response to long-term bisphosphonate therapy in four patients with osteoporosis-pseudoglioma syndrome. | Am J Med Genet A | 2022 | 35393770 | PubTator, text mining | PubMed |
| Osteoporosis in children and adolescents: when to suspect and how to diagnose it. | Eur J Pediatr | 2022 | 35384509 | PubTator, text mining | PubMed |
| Emerging Role of Clinical Genetics in CKD. | Kidney Med | 2022 | 35372818 | PubTator, text mining | PubMed |
| Clinical practice guidelines for optimizing bone health in Korean children and adolescents. | Ann Pediatr Endocrinol Metab | 2022 | 35368191 | PubTator, text mining | PubMed |
| Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells. | BMC Pharmacol Toxicol | 2022 | 35366954 | PubTator, text mining | PubMed |
| Efficacy and safety of acupuncture on oligomenorrhea due to polycystic ovary syndrome: An international multicenter, pilot randomized controlled trial. | Medicine (Baltimore) | 2022 | 35363161 | PubTator, text mining | PubMed |
| Lessons learned: next-generation sequencing applied to undiagnosed genetic diseases. | J Clin Invest | 2022 | 35362483 | PubTator, text mining | PubMed |
| Circular RNA circStag1 promotes bone regeneration by interacting with HuR. | Bone Res | 2022 | 35361779 | PubTator, text mining | PubMed |
| The Influence of Acupuncture Parameters on Efficacy and the Possible Use of Acupuncture in Combination with or as a Substitute for Drug Therapy in Patients with Ulcerative Colitis. | Evid Based Complement Alternat Med | 2022 | 35360658 | PubTator, text mining | PubMed |
Assessment of quality of life and activities of daily living among elderly patients with hypertension and impaired physical mobility in home health care by antihypertensive drugs plus acupuncture: A CONSORT-compliant, randomized controlled trial. | Medicine (Baltimore) | 2022 | 35356935 | PubTator, text mining | PubMed |
| Drug Discovery of DKK1 Inhibitors. | Front Pharmacol | 2022 | 35355709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=45